Showing 1-10 of 13 results for "".
“Turn-Key” Hair Restoration Requires Caution: The Specialist's Perspective
https://modernaesthetics.com/ma-issues-index/2019-july-aug/turn-key-hair-restoration-requires-caution-the-specialists-perspective/34023/Surgeons must protect their role and establish their expertise now and for the future.- Jeffrey Epstein, MDhttps://modernaesthetics.com/profiles/jeffrey-epstein-md/LqJGVB/
- Jeffrey Epstein, MD, FACS, FISHRShttps://modernaesthetics.com/profiles/jeffrey-epstein-md-facs-fishrs/j5eaMx/
MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data from- Jeffrey Bettinger Joins Establishment Labs as Global Head of Peoplehttps://modernaesthetics.com/news/jeffrey-bettinger-joins-establishment-labs-as-global-head-of-people/2473162/Industry vet Jeffrey Bettinger is the new Global Head of People at Establishment Labs Holdings Inc. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants, and also
- Coming This Week: Cutera AviClear Webinarhttps://modernaesthetics.com/news/coming-this-week-cutera-aviclear-webinar/2473230/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn
- Jeffrey Cohenhttps://modernaesthetics.com/profiles/jeffrey-cohen/OKAN45/
- Jeffrey Hsuhttps://modernaesthetics.com/profiles/jeffrey-hsu/Oww53G/
- Jeffrey Dover, MDhttps://modernaesthetics.com/profiles/jeffrey-dover-md/jPKY04/
- Prev
- Next